Resources

Isaac Health is an accepted participant in CMS GUIDE Model Program

NEW YORK, New York, April 9, 2024 – Isaac Health, a leading national provider of brain health and dementia care, has been accepted in the established and new model tracks of the ​​Centers for Medicare & Medicaid Services’ (CMS) Guiding an Improved Dementia Experience (GUIDE) Model.  The GUIDE Model focuses on enhancing care for individuals …

Isaac Health is an accepted participant in CMS GUIDE Model Program Read More »

Isaac Health joins ALZ-NET as a participating telehealth site

Isaac Health has recently become a participating site in the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET). Sponsored by the Alzheimer’s Association and managed by the American College of Radiology, ALZ-NET is a collaborative effort to improve brain health outcomes across the nation and drive innovation in the ways we care for and treat Alzheimer’s disease and other dementias.

Utilization management

White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management

Introduction: The recent full approval of Lecanemab (Leqembi) by the FDA has ushered in a new era in the treatment of Alzheimer’s disease. As the first disease-modifying treatment to receive such approval, Leqembi offers hope to patients with early-stage Alzheimer’s. However, its adoption poses cost implications for payers and risk-bearing health systems. In a newly …

White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management Read More »

Neurologist with brain scan

Leqembi – Implications for Health Insurance Payers: A Comprehensive Analysis

Introduction: On July 6, 2023, the FDA granted full approval to Lecanemab (Leqembi), marking a significant milestone as the first disease-modifying treatment for Alzheimer’s disease to receive such approval. This white paper aims to inform health insurance employees about the implications of Leqembi’s approval and offer insights into coverage considerations and potential cost implications. Coverage …

Leqembi – Implications for Health Insurance Payers: A Comprehensive Analysis Read More »

Image of FDA Building

FAQ About Leqembi

About Leqembi Leqembi is the first of (very likely) many forthcoming drugs that will be revolutionizing the landscape of early stage Alzheimer’s disease. With its traditional (full) FDA approval come new questions from our patients and community surrounding its availability, manufacturer, purchasing options, working mechanism, insurance coverage, and comparisons with other medications. Our doctors here …

FAQ About Leqembi Read More »

President Carter and First Lady Rosalynn Carter dance at the annual Congressional Christmas Ball at the White House in 1978 in Washington, D.C. (Ira Schwarz / Associated Press)

Insights on former First Lady, Rosalynn Carter’s Diagnosis

Rosalynn Carter, the former First Lady and a prominent advocate for mental health care, has been diagnosed with dementia, as announced by the Carter Center and reported by the New York Times. This revelation follows her husband, former President Jimmy Carter’s decision to enter hospice care. Despite the diagnosis, Mrs. Carter, at 95 years old, …

Insights on former First Lady, Rosalynn Carter’s Diagnosis Read More »

Select evidence for the prevention of Alzheimer’s Disease

FINGER study on Alzheimer prevention suggesting a multidomain intervention is effective in preventing a significant proportion of Alzheimer cases: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60461-5/fulltext Global study based on the FINGER study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222931/ CAIDE study on addressable Alzheimer Risk Factors: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(06)70537-3/fulltext Helpful overview of all risk factors and prevention recommendations: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2244657/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514088/ The approach of the Weill Cornel Alzheimer prevention …

Select evidence for the prevention of Alzheimer’s Disease Read More »

Resources for caregivers

Alzheimers.gov has put together a series of websites to help caregivers navigate the journey of caring for the loved ones: National Institute on Aging (NIA)Advance Care Planning Learn about financial and health care planning, including advance directives. National Institute on Aging (NIA)Alzheimer’s Caregiving Learn how to respond to changes in communication and behavior, provide everyday …

Resources for caregivers Read More »

Alzheimer’s Universe

The Alzheimer’s Universe is a collection of resources put together by Weill Cornell Medicine on Alzheimer prevention:   AlzU.org was created by a team of experts to offer the most up-to-date information on Alzheimer’s disease (AD) prevention, treatment and caregiving. Join now to access one of 6 free online courses – one that focuses primarily on AD …

Alzheimer’s Universe Read More »

Join our community

* indicates required

Request patient flyers